IFX-2

N/A

Report date: 2023/04/14 10:24:53

Base Information

Drug NameIFX-2
Drug Alias NameIFX-2IFX-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionComplement C5a inhibitors
TargetsComplement C5a
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInflarx
China Registration ClassN/A

Develop Information

Active CompaniesInflarx
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A